etoposide has been researched along with nad in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 9 (52.94) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campbell, RJ; Laws, ER; Saez, RJ | 1 |
| Fox, RM; Marks, DI | 1 |
| Berger, NA; Berger, SJ; Chatterjee, S; Hashimoto, H; Tsai, ML; Whitacre, CM | 1 |
| Berger, NA; Berger, RB; Berger, SJ; Chatterjee, S; Cheng, MF | 1 |
| Berger, NA; Berger, SJ; Chatterjee, S; Cheng, MF | 1 |
| Davidson, NE; Desnoyers, S; Kaufmann, SH; Ottaviano, Y; Poirier, GG | 1 |
| Cossman, J; Jorgensen, TJ; Kamesaki, H; Kamesaki, S; Pommier, Y; Tanizawa, A | 1 |
| Bernardi, R; Donzelli, M; Guano, F; Negri, C; Prosperi, E; Scovassi, AI; Torti, M | 1 |
| Bello, BD; Comporti, M; Maellaro, E | 1 |
| Bernardi, R; Poirier, GG; Rossi, L; Scovassi, AI | 1 |
| Alexandre, S; Nguyen-Ba, G; Poirier, GG; Rast, C; Vasseur, P | 1 |
| Jacobson, EL; Katschinski, DM; Robins, HI; Wiedemann, GJ | 1 |
| Kirkland, JB; Spronck, JC | 1 |
| Chang, I; Cho, N; Koh, JY; Lee, MS | 1 |
| Kirkland, JB; Nickerson, JL; Spronck, JC | 1 |
| Gratas, C; Nadaradjane, A; Oizel, K; Oliver, L; Pecqueur, C; Vallette, FM | 1 |
17 other study(ies) available for etoposide and nad
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Chemotherapeutic trials on human malignant astrocytomas in organ culture.
Topics: Antineoplastic Agents; Astrocytoma; Carmustine; Cell Survival; Cyanides; Drug Evaluation, Preclinical; Etoposide; Humans; Lomustine; Luciferases; Methylprednisolone; NAD; Organ Culture Techniques | 1977 |
DNA damage, poly (ADP-ribosyl)ation and apoptotic cell death as a potential common pathway of cytotoxic drug action.
Topics: Adenosine Triphosphate; Biotransformation; Cell Death; Cell Division; Cyclophosphamide; DNA Damage; Etoposide; Humans; NAD; Poly(ADP-ribose) Polymerases; Time Factors; Tumor Cells, Cultured | 1991 |
Involvement of NAD-poly(ADP-ribose) metabolism in p53 regulation and its consequences.
Topics: Animals; Apoptosis; Cells, Cultured; Cricetinae; Cricetulus; Etoposide; Fibroblasts; Humans; Luciferases; NAD; Niacinamide; Poly Adenosine Diphosphate Ribose; Transcription, Genetic; Tumor Suppressor Protein p53; Up-Regulation | 1995 |
Effect of inhibitors of poly(ADP-ribose) polymerase on the induction of GRP78 and subsequent development of resistance to etoposide.
Topics: 6-Aminonicotinamide; Animals; Benzamides; Carrier Proteins; Cricetinae; Cricetulus; Drug Resistance; Endoplasmic Reticulum Chaperone BiP; Etoposide; Heat-Shock Proteins; Isoquinolines; Molecular Chaperones; NAD; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Substance Withdrawal Syndrome; Transcription, Genetic | 1995 |
Induction of M(r) 78,000 glucose-regulated stress protein in poly(adenosine diphosphate-ribose) polymerase- and nicotinamide adenine dinucleotide-deficient V79 cell lines and its relation to resistance to the topoisomerase II inhibitor etoposide.
Topics: Animals; Cell Line; Cell Survival; Cricetinae; Cricetulus; Drug Resistance; Etoposide; Glucose; Heat-Shock Proteins; Molecular Weight; NAD; Poly(ADP-ribose) Polymerases | 1994 |
Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Etoposide; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Molecular Weight; NAD; Peptide Fragments; Poly(ADP-ribose) Polymerases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protease Inhibitors | 1993 |
bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair.
Topics: Animals; Apoptosis; DNA Damage; DNA Repair; Etoposide; Mice; NAD; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1993 |
Activation of poly(ADP-ribose)polymerase in apoptotic human cells.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Benzamides; Cell Nucleus; DNA, Neoplasm; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Enzyme Inhibitors; Etoposide; HeLa Cells; Humans; NAD; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases | 1995 |
Protection by ascorbate against apoptosis of thymocytes: implications of ascorbate-induced nonlethal oxidative stress and poly(ADP-ribosyl)ation.
Topics: Animals; Apoptosis; Ascorbic Acid; Dehydroascorbic Acid; DNA; Enzyme Inhibitors; Etoposide; Free Radicals; Hydrogen Peroxide; Male; Methylprednisolone; NAD; Neuroprotective Agents; Oxidative Stress; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Terpenes; Thapsigargin; Thymus Gland | 1996 |
Analysis of poly(ADP-ribose) glycohydrolase activity in nuclear extracts from mammalian cells.
Topics: Adenosine Diphosphate Ribose; Animals; Autoradiography; Cell Nucleus; CHO Cells; Chromatography, Thin Layer; Cricetinae; Ethacridine; Etoposide; Glycoside Hydrolases; HeLa Cells; HL-60 Cells; Humans; Kinetics; NAD; Neuroblastoma; Phosphorus Radioisotopes; Tumor Cells, Cultured | 1997 |
PARP degradation in apoptotic Syrian hamster embryo (SHE) cells compared to HL60 cell line.
Topics: Animals; Apoptosis; Blotting, Western; Cell Line; Cricetinae; Culture Media, Serum-Free; DNA Fragmentation; Embryo, Mammalian; Etoposide; HL-60 Cells; Humans; Mesocricetus; NAD; Poly(ADP-ribose) Polymerases | 2000 |
Modulation of VP-16 cytotoxicity by carboplatin and 41.8 degrees C hyperthermia.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Western; Carboplatin; Cell Survival; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum Chaperone BiP; Etoposide; Fibrosarcoma; Hyperthermia, Induced; Mice; NAD; Time Factors; Tumor Cells, Cultured | 2001 |
Niacin deficiency increases spontaneous and etoposide-induced chromosomal instability in rat bone marrow cells in vivo.
Topics: Animals; Bone Marrow Cells; Cell Division; Chromosome Fragility; DNA Damage; Etoposide; Kinetics; Male; Micronucleus Tests; Mutagenicity Tests; NAD; Niacin; Poly Adenosine Diphosphate Ribose; Rats; Rats, Long-Evans; Sister Chromatid Exchange | 2002 |
Pyruvate inhibits zinc-mediated pancreatic islet cell death and diabetes.
Topics: Adenosine Triphosphate; Animals; Antigens, Polyomavirus Transforming; Antioxidants; Cell Death; Cell Line, Tumor; Cell Transformation, Neoplastic; Diabetes Mellitus, Experimental; Etoposide; Insulinoma; Interferon-gamma; Islets of Langerhans; NAD; Necrosis; Pancreatic Neoplasms; Pyruvic Acid; Rats; Rats, Sprague-Dawley; Staurosporine; Tumor Necrosis Factor-alpha; Zinc | 2003 |
Niacin deficiency alters p53 expression and impairs etoposide-induced cell cycle arrest and apoptosis in rat bone marrow cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Bone Marrow Cells; Cell Cycle; Cell Proliferation; DNA Damage; Etoposide; Genes, p53; In Situ Nick-End Labeling; NAD; Niacin; Poly Adenosine Diphosphate Ribose; Polymerase Chain Reaction; Random Allocation; Rats; Rats, Long-Evans; Vitamin B Complex; Vitamin B Deficiency | 2007 |
D-2-Hydroxyglutarate does not mimic all the IDH mutation effects, in particular the reduced etoposide-triggered apoptosis mediated by an alteration in mitochondrial NADH.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Etoposide; Gene Expression Regulation, Neoplastic; Glioma; Glutarates; Humans; Isocitrate Dehydrogenase; Ketoglutarate Dehydrogenase Complex; Mitochondria; Mutation; NAD | 2015 |